Priaxon and Munich Technical University Hospital Announce Cooperation for the Development of Novel Anti-Infectives with Novel Mode of Action

Published: Nov 08, 2010

MUNICH--(BUSINESS WIRE)--Priaxon AG, Munich, and the University Hospital Rechts der Isar (Technical University Munich) announce their cooperation for the development of new, highly selective anti-infective agents against a novel protein target class of widely spread infectious diseases. Their joint project is supported in the framework of the top cluster support project of the German Federal Ministry of Education and Research, coordinated by BioM GmbH. In the context of this top cluster support the Munich biotech region was awarded altogether EUR 40 mio., doubled by an additional amount of EUR 40 mio. in industry funding, and further raised by approx. EUR 12 mio. from the Free State of Bavaria, over a funding period of five years.

Back to news